Cetera Trust Company’s Quest Diagnostics DGX Stock Holding History

Cetera Trust Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.88K	Hold	30	–	–	﹤0.01%	330
2025 Q4	$5.21K	Hold	30	–	–	﹤0.01%	338
2025 Q3	$5.72K	Hold	30	–	–	﹤0.01%	330
2025 Q2	$5.39K	Hold	30	–	–	﹤0.01%	336
2025 Q1	$5.08K	Hold	30	–	–	﹤0.01%	345
2024 Q4	$4.53K	Hold	30	–	–	﹤0.01%	366
2024 Q3	$4.66K	Hold	30	–	–	﹤0.01%	374
2024 Q2	$4.11K	Hold	30	–	–	﹤0.01%	381
2024 Q1	$3.99K	Hold	30	–	–	﹤0.01%	392
2023 Q4	$4.14K	Buy	+30	New	+$3.94K	﹤0.01%	382

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Cetera Trust Company's DGX Position: Q1 2026 in Review

Cetera Trust Company held its Quest Diagnostics (DGX) position steady in Q1 2026 at 30 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

Cetera Trust Company first reported a position in DGX in Q4 2023 and has held it in 10 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Cetera Trust Company held 30 shares of Quest Diagnostics worth $5.88K as of Q1 2026.
Cetera Trust Company left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up ﹤0.01% of Cetera Trust Company's portfolio in Q1 2026, its #330 holding.
Cetera Trust Company first reported a position in Quest Diagnostics in Q4 2023 and has held it in 10 quarters since.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.